Cyclins and cyclin‐dependent kinases (CDKs) are frequently dysregulated in human cancers and represent compelling therapeutic targets. Beyond their well‐recognized roles in cell cycle control, CDK/cyclin complexes orchestrate diverse oncogenic processes, including transcription, genome maintenance, epigenetics, metabol...
Suya Zheng, Zhi-Peng Shen, Yuan-Fang Wu et al.· MedComm· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.